Day One – Wednesday, September 6th, 2017

7:30am - 8:50am

7:30am - 8:50am

Registration Opens & Continental Breakfast for Attendees

8:50am - 9:00am

8:50am - 9:00am

Chairperson’s Day One Welcome and Opening Remarks

GENERAL SESSION PLENARIES

9:00am - 9:45am

9:00am - 9:45am

Commercializing Extended Release Delivery of Drugs in Oral Liquid Dosage Form

Ketan Mehta PhD

Ketan Mehta PhD

President & CEO, Tris Pharma

9:45am - 10:30am

9:45am - 10:30am

Developing Sustained Release Formulations for Oral Delivery

Jay Lakshman, PhD

Jay Lakshman, PhD

Project Leader and Technology Platform Leader, Novartis

10:30am - 11:00am

10:30am - 11:00am

Morning Networking & Refreshment Break in Exhibit Hall

11:00am - 11:45am

11:00am - 11:45am

Next Generation Product Development: Developing and Commercializing D-Amino Acid Proteins and the Opportunities for Novel Drug Delivery

Dana Ault-Riche, PhD.

Dana Ault-Riche, PhD.

Chief Executive Officer, Reflexion Pharmaceuticals

11:45am - 12:30pm

11:45am - 12:30pm

PANEL SESSION: Exploring Innovative Collaboration Models to Accelerate Next Generation Product Development
Rakesh Dixit, PhD.

Rakesh Dixit, PhD.

Vice President, Research & Development, ‎MedImmune (AstraZeneca Biologics)

Christopher A. Rhodes, PhD.

Christopher A. Rhodes, PhD.

President & CEO, Drug Delivery Experts

Esmaiel Jabbari, PhD.

Esmaiel Jabbari, PhD.

Professor of Chemical Engineering University of South Carolina

Dana Ault-Riche, PhD.

Dana Ault-Riche, PhD.

Chief Executive Officer, Reflexion Pharmaceuticals

12:30pm - 1:30pm

12:30pm - 1:30pm

Networking Lunch

4th Annual Controlled & Modified Drug Release
3rd Drug Delivery Strategy: Advanced Mechanisms & Product Design
2nd Peptide Drug Design & Delivery Summit

1:30pm - 2:10pm

1:30pm - 2:10pm

Breakthrough Innovations in the Next Generation of Controlled Delivery Systems

Esmaiel Jabbari, PhD.

Esmaiel Jabbari, PhD.

Professor of Chemical Engineering University of South Carolina

The Importance of Identifying and Serving User Needs and Managing the Associated Risks

Molly Story, PhD.

Molly Story, PhD.

Head, Global Usability Engineering and Risk Management, Medical Device Development Unit, Sanofi

Overcoming Drug Delivery Barriers for Peptide-Based Drug Products: Approaches and Strategies

Christopher A. Rhodes, PhD.

Christopher A. Rhodes, PhD.

President & CEO, Drug Delivery Experts

2:10pm - 2:50pm

2:10pm - 2:50pm

Achieving Precision Drug Delivery and Enabling Patient Compliance Through a Microchip-Based Delivery System

Liz Proos,

Liz Proos,

Director, Formulation Development, Microchips Biotech, Inc.

Long-Acting Implants: A Novel Therapeutic Modality that can Assist Adherence and Compliance

Alex Schwarz, PhD

Alex Schwarz, PhD

Vice President, Early Development, Braeburn Pharmaceuticals, Inc

PANEL SESSION: Examining Futuristic Platforms for the Discovery of New Peptide Therapeutics

Laszlo Otvos, PhD.

Laszlo Otvos, PhD.

Adjunct Professor, Semmelweis Medical School

Amit Joshi, PhD.

Amit Joshi, PhD.

Senior Manager, Advanced Sourcing & Innovation, Johnson & Johnson

2:50pm - 3:30pm

2:50pm - 3:30pm

Panel Session: Evolving Controlled Release Technologies to Support the Next Generation of Drug Delivery

Rakesh Dixit, PhD.

Rakesh Dixit, PhD.

Vice President, Research & Development, ‎MedImmune (AstraZeneca Biologics)

Delivering Therapy to Target: Improving the odds for Successful Drug Development

Raghu Raghavan, PhD

Raghu Raghavan, PhD

President and Co-Founder, Therataxis, LLC

Advances in Solubilization, Protection, and Delivery of Oral Peptides with SEDDS

Vincent Jannin, PhD.

Vincent Jannin, PhD.

Research Director, Pharmaceuticals, Gattefossé

3:30pm - 4:00pm

3:30pm - 4:00pm

Afternoon Networking & Refreshment Break in Exhibit Hall

4:00pm - 4:40pm

4:00pm - 4:40pm

Combination Products: Examining how Quality by Design (QbD) can Aid Formulation of Targeted Delivery

Abizer Harianawala, PhD

Abizer Harianawala, PhD

Senior Director - Product Development and Technical Operations, TARIS Biomedical

Evolution of Nanoparticle Delivery: Targeted Approaches in Oncology Drug Development

Shaker Mousa, PhD

Shaker Mousa, PhD

Chairman & Executive Vice President, The Pharmaceutical Research Institute

Commercial Advances and Opportunities in Antimicrobial Peptides in Immunotherapy

Laszlo Otvos, PhD.

Laszlo Otvos, PhD.

Adjunct Professor, Semmelweis Medical School

4:40pm - 5:20pm

4:40pm - 5:20pm

Innovative Approaches for Ligand-Targeted Drug Design

Anthony Tuesca, PhD

Anthony Tuesca, PhD

Senior Scientist, Formulation Sciences, MedImmune

Next Generation Non-Invasive Delivery: Targeted Delivery of Nanoparticles to the Brain

Susan Rosenbaum, JD.

Susan Rosenbaum, JD.

Founder, Chairman & Chief Executive Officer, Lauren Sciences LLC

Novel Approaches for Improving Peptide Stability

Sonia Bedi, PhD

Sonia Bedi, PhD

Principal Scientist, Biopharm Product Sciences, Biopharm R&D, GlaxoSmithKline

5:20pm - 5:30pm

5:20pm - 5:30pm

Chair’s Closing Remarks and Wrap-Up of Day One

5:30pm

5:30pm

Cocktail Reception in Exhibit Hall

Day Two – Thursday, September 7th, 2017

8:00am - 8:50am

8:00am - 8:50am

Registration Opens & Continental Breakfast for Attendees

4th Annual Controlled & Modified Drug Release
3rd Drug Delivery Strategy: Advanced Mechanisms & Product Design
2nd Peptide Drug Design & Delivery Summit

8:50am - 9:00am

8:50am - 9:00am

Chairperson’s Day Two Welcome and Opening Remarks

9:00am - 9:40am

9:00am - 9:40am

Optimal Parenteral Sustained Release Drug Delivery

Joseph Della Rocca

Joseph Della Rocca

Senior Scientist, Merck & Co.

Enhanced Bioavailability of Drugs for Malaria, TB and Neglected Diseases using Cost Effective, Continuous Processes

Robert Prud'homme, PhD.

Robert Prud'homme, PhD.

Professor, Department of Chemical & Biological Engineering, Princeton University

Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptide

Rebecca Nofsinger, PhD.

Rebecca Nofsinger, PhD.

Senior Research Pharmacist, Merck & Co.

9:40am - 10:20am

9:35am - 10:10am

An Integrated Biopharmaceutics Approach for Effective Drug Development for Clinical Trials

Donald Dickison, PhD.

Donald Dickison, PhD.

Vice President, Business Development, Juniper Pharma Services

Formulation Development Advances in Pediatric Dosage Form

Anthony Qu, PhD

Anthony Qu, PhD

Vice President, Drug Product Development, Halo Pharmaceuticals

Developing Sustained Release Formulations: Intacia’s Medici Drug Delivery System

Scott Peterson, PhD.

Scott Peterson, PhD.

Executive Director, Corporate Development, Intarcia Therapeutics

10:20am - 11:00am

10:20am - 11:00am

Ocular Delivery: Sustained and Targeted Drug Delivery Systems

Viral Kansara, PhD.

Viral Kansara, PhD.

Investigator and Head of Ocular Pharmacology and Drug Delivery Laboratory, Novartis

Nanoparticle Fabrication in Pharmaceutical Formulation Development

Ghazal Hariri, PhD

Ghazal Hariri, PhD

Senior Scientist, Drug Delivery Systems, Pfizer, Inc.

Approaches to Explore Intranasal and Intraoral Peptide Delivery

Zhen Yang, PhD.

Zhen Yang, PhD.

Associate Principal Scientist, Biopharmaceutics & Specialty Dosage Form, Merck & Co.

11:00am - 11:30am

11:00am - 11:30am

Morning Networking & Refreshment Break in Exhibit Hall

11:30am - 12:10pm

11:30am - 12:10pm

Novel Controlled Drug Delivery Application for Intralesional Administration of Antifungal Drugs for Onychomycosis Treatment

Muralikrishnan Angamuthu, PhD.

Muralikrishnan Angamuthu, PhD.

Formulation Development Scientist, GlaxoSmithKline

PBPK Modeling and Simulations of Oral Drug Absorption: Opportunities and Challenges

Tycho Heimbach, PhD.

Tycho Heimbach, PhD.

Director, PK Sciences Team Lead Computational and Biopharmaceutic, ADME, Novartis

Novel, High-Loading Encapsulation of Peptides and Biologics into Nanoparticle and Microparticle Forms

Robert Prud'homme, PhD.

Robert Prud'homme, PhD.

Professor, Department of Chemical & Biological Engineering, Princeton University

12:10pm - 12:50pm

12:10pm - 12:50pm

Oral Modified Release - Novel Formulations, Technologies and Development Strategies

Ronald Vladyka, PhD

Ronald Vladyka, PhD

Director, Formulations Research & Development, Catalent Pharma Solutions

Targeted Drug Delivery to Bone

Charles McKenna, PhD.

Charles McKenna, PhD.

Professor of Chemistry & Pharmaceutical Sciences, University of Southern California

Accurate Computational Design of Hyper-Stable Constrained Peptides

Gaurav Bhardwaj, PhD.

Gaurav Bhardwaj, PhD.

Head of the Institute for Protein Design, Professor of Biochemistry, University of Washington

12:50pm - 2:00pm

12:50pm - 2:00pm

Networking Lunch

2:00pm - 2:40pm

2:00pm - 2:40pm

Improving Adherence with Patient-Centric Modified Release Formulations: Transforming Oral Delivery Challenges into Proprietary Product Solutions

Rubi Burlage, PhD

Rubi Burlage, PhD

Director, Formulation Sciences, Merck & Co.

Recent Advances in Ocular Delivery of Biologics

Brian Pan, PhD.

Brian Pan, PhD.

Co-Founder & CEO, BioHealthWays

David Pan, PhD.

David Pan, PhD.

Chief Technology Officer, BioHealthWays

Overcoming Drug Development Barriers for Peptide Products: Analytical, Physical and Formulation Aspects

Tian Wu, PhD.

Tian Wu, PhD.

Senior Scientist, Drug Product Technology, Amgen

2:40pm - 3:00pm

2:40pm - 3:00pm

Afternoon Networking & Refreshment Break in Exhibit Hall

3:00pm - 3:40pm

3:00pm - 3:40pm

Rapid and Efficient Reformulation of an Immediate Release Formulation with TID Regimen to CR Formulations with BID Regimen via Adaptive Clinical Design

Irina Kadiyala, PhD.

Irina Kadiyala, PhD.

Senior Scientist, Delivery Systems, Vertex Pharmaceuticals

Formulation Selection and In-Silico Design for Extended Release Products

Alfred Berchielli,

Alfred Berchielli,

Senior Principal Scientist, Drug Product Design, Pfizer, Inc.

Next Generation Injectable Peptide Drug Products: Formulation Challenges and Strategies

Marian Gindy, PhD.

Marian Gindy, PhD.

Director and Head of Sterile Products Development, Merck & Co.

3:40pm - 3:45pm

3:40pm - 3:45pm

Chair’s Closing Remarks and Close of Conference

Pin It on Pinterest

Share This